Categories AlphaGraphs, Earnings, Health Care

Infographic: Highlights of UnitedHealth Group’s (UNH) Q2 2023 earnings

Diversified healthcare company UnitedHealth Group (NYSE: UNH) reported higher earnings and revenues for the second quarter of 2023. The company also raised its full-year earnings guidance.

UnitedHealth Group Q2 2023 earnings infographic

Second-quarter revenues grew 16% year-over-year to $92.9 billion, reflecting strong growth across all business segments. Net earnings attributable to shareholders rose to $5.47 billion or $5.82 per share in Q2 from $5.07 billion or $5.34 per share in the same period of 2022.

Adjusted earnings, excluding special items, increased 10% annually to $6.14 per share. UnitedHealth raised the range of its full-year net earnings forecast to $23.45 to $23.75 per share and adjusted earnings per share guidance to $24.70 to $25.00 per share.

“Our diverse healthcare capabilities and dedicated colleagues are enabling us to meet the needs of more people in more ways, driving substantial growth and expanding our opportunities to serve well into the future,” said Andrew Witty, the company’s chief executive officer.

Prior Performance

  • UnitedHealth-Group-Q3-2022-Earnings-Infographic
  • UnitedHealth-Group-Q4-2022-Earnings-Infographic-1
  • UnitedHealth Group Q2 2022 Earnings Infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Viewing Highlight